Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022568 (
keratitis
)
5,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cathodal (-) iontophoresis of 9-beta-D-arabinofuranosyl-adenine 5'-monophosphate (vidarabine monophosphate;
Ara-AMP
) was performed once daily for 3 days for the treatment of experimental herpes simplex virus type 1 (HSV-1)
keratitis
in rabbit eyes, and the therapeutic efficacy was compared with that of topical treatment of
Ara-AMP
and idoxuridine (IDU) administered five times daily for 4 days. With the treatment initiated 24 hr after viral inoculation,
Ara-AMP
cathodal iontophoresis resulted in significant suppression of epithelial and anterior segment disease processes. Topical IDU (0.5%) or
Ara-AMP
(10%) also significantly improved the disease process when compared to the placebo-treated group; however, iontophoresis of
Ara-AMP
resulted in a more marked improvement. Slit-lamp examination indicated that iontophoresis did not cause any observable pathologic changes in corneal epithelium, stroma, conjunctiva, or iris of rabbit eyes. This experiment suggests that iontophoresis of
Ara-AMP
is a safe and effective approach for preventing the development of herpes simplex
keratitis
in rabbits.
...
PMID:Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits. 9 30
Adenine arabinoside monophosphate
(
Ara-AMP
) demonstrated antiviral activity equivalent to adenine arabinoside (Ara-A) against herpesvirus Types 1 and 2 in tissue culture. Against established herpes virus Type 1 epithelial
keratitis
in rabbits,
Ara-AMP
2 per cent was comparable in efficacy to Ara-A 3 per cent, and
Ara-AMP
20 per cent was superior to Ara-A 3 per cent. These results are especially significant in that Ara-A's high solubility will permit (1) more concentrated formulations to be presented topically and (2) adequate absorption by parenteral routes with smaller fluid loads than required for Ara-A.
...
PMID:Anti-herpes activity of adenine arabinoside monophosphate. 125 7